Severe spruelike enteropathy associated with olmesartan

Mayo Clinic Proceedings

Volumn 87, Issue 8, 2012, Pages 732-738

  Rubio Tapia, Alberto ^a   Herman, Margot L ^b   Ludvigsson, Jonas F ^a,c,d   Kelly, Darlene G ^a   Mangan, Thomas F ^a   Wu, Tsung Teh ^a   Murray, Joseph A ^a  

^a MAYO CLINIC   (United States)

^b Department of Internal Medicine ^*  (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIDIARRHEAL AGENT; ATENOLOL; AZATHIOPRINE; BILE ACID SEQUESTRANT; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; BUDESONIDE; CARVEDILOL; CORTICOSTEROID; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; METRONIDAZOLE; OCTREOTIDE; OLMESARTAN; PANCREAS ENZYME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SPIRONOLACTONE; TRIAMTERENE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL ARTICLE; COLLAGEN DEPOSITION; COLLAGENOUS GASTRITIS; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUODENUM; ENTEROPATHY; FEMALE; FOLLOW UP; GASTRITIS; GLUTEN FREE DIET; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; LYMPHOCYTIC GASTRITIS; MALE; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PROTEIN METABOLISM; SPRUELIKE ENTEROPATHY; SYMPTOMATOLOGY; TREATMENT RESPONSE; UNITED STATES; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84866370242     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.06.003     Document Type: Article

References (28)

1. Ziegler TR, Fernández-Estívariz C, Gu LH, Fried MW, Leader LM. Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology. 2003;124(7):1950-1957. (Pubitemid 36666790)
2. Kamar N, Faure P, Dupuis E, et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int. 2004;17(8):463-467. (Pubitemid 39362576)
3. Weclawiak H, Ould-Mohamed A, Bournet B, et al. Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation. Am J Transplant. 2011;11(3):575-582.
4. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010;8(4):344-349.e3.
5. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97(8):2016-2021.
6. Global Database on Body Mass Index. World Health Organization Web site. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html. Updated August 6, 2011. Accessed April 12, 2012.
7. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and-DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993;41(3):119-134. (Pubitemid 23139836)
8. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17(1):85-91. (Pubitemid 40136613)
9. Chorzelski TP, Beutner EH, Sulej J, et al. IgA anti-endomysium antibody: a new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol. 1984;111(4):395-402. (Pubitemid 14006288)
10. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut. 1994;35(6):776-778. (Pubitemid 24193220)
11. Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5(11):1282-1290; quiz 1245. (Pubitemid 350019047)
12. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 1992;102(1):330-354.
13. Patey-Mariaud De Serre N, Cellier C, Jabri B, et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 2000;37(1):70-77. (Pubitemid 30496738)
14. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol. 1997;151(2):493-498. (Pubitemid 27330068)
15. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140(4):1155-1165.
16. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131(6):1981-2002. (Pubitemid 44958523)
17. Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105(6):1412-1420.
18. Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol. 2002;118(3):459-463. (Pubitemid 37046345)
19. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98(4):839-843. (Pubitemid 36576311)
20. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43(2):157-161.
21. Teo M, Chung S, Chitti L, et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol. 2004;19(8):904-909. (Pubitemid 39093208)
22. Matt P, Schoenhoff F, Habashi J, et al; GenTAC Consortium. Circulating transforming growth factor-beta in Marfan syndrome. Circulation. 2009;120(6):526-532.
23. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest. 1994;93(6):2431-2437. (Pubitemid 24177156)
24. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920-1925. (Pubitemid 40404695)
25. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev. 2005;204:184-194. (Pubitemid 40460502)
26. Scott LJ, McCormack PL. Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs. 2008;68(9):1239-1272. (Pubitemid 351822113)
27. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169(1):345-350. (Pubitemid 19035567)
28. Kaukinen K, Partanen J, Mäki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 2002;97(3):695-699. (Pubitemid 34245900)